Additional Influenza Vaccine Approved For Upcoming Influenza Season - Approval Increases Available Doses To Record Level
The U.S. Food and Drug Administration approved Afluria, an additional seasonal influenza vaccine for the immunization of people ages 18 and older.Afluria is intended to protect adults from influenza type A and type B flu viruses. Influenza is a contagious respiratory illness that can cause annual epidemics. The approval of Afluria, manufactured by CSL Limited of Parkville, Australia, brings the number of seasonal influenza manufacturers licensed for the U.S.
